My $$ is on PE.

Cisbio markey is drying up. Screens are getting smaller in size and fewer are being run. They cannot survive by simply broadening their assay portfolio - something radical needs to happen

I remember Sigma took a good hard look at them around 1999, but the French...ooh la la, the French were completely unreasonable and had unrealistic expectations. The reality the only truly homogenous immunoassay technology was never successfully commercialized

15 years ago maybe...